Our recent research revealed high anti-proliferative and pro-apoptotic activity of plumbagin towards HER2-overexpressing breast cancer cells [14], therefore our present research focuses on determining the ability of plumbagin to inhibit HER2-positive breast cancer cell invasion and defining the mechanism of plumbagin-mediated cell invasion inhibition. The gene discussed is ERBB2; the disease is breast carcinoma.